Skip to Main Content

Current Funding Opportunities

Click here to visit the NCI grant site.

Use your device's search function to find a specific disease or funding source. 


Funding

The Vera and Joseph Dresner Foundation  MDS Research Fund
The fund will facilitate the advancement of innovative basic science, translational or clinical research to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders (such as MDS/myeloproliferative neoplasms (MPN) overlap syndromes, secondary acute myeloid leukemia following MDS, idiopathic cytopenia of undetermined significance (ICUS), or clonal hematopoiesis of indeterminate potential (CHIP). 

The foundation will consider proposals from individuals at university, college, hospital, or laboratory institutions for support of research in MDS or related disorders in two types:
- Early Career Awards 
- Established Investigator Awards

Letter of Intent (LOI) Deadline: LOIs are accepted on a rolling basis. 
Learn More>> 

Human Health Exposure Analysis Resource (HHEAR)

The HHEAR Program enables NCI-funded researchers to integrate environmental exposures into their existing studies by providing access to high-quality, exposure-assessment services, including: state of the art targeted laboratory analysis of biological samples; statistical analysis services; and expert consultation on exposure analysis, study design, and data analysis and interpretation.

Application Deadline: February 28, 2020

Learn more about the HHEAR award>>


Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01)

The purpose of this FOA is to encourage revision applications (formerly called "competing revisions") from currently funded NCI R01 research projects. The applicants should propose projects that are expected to accelerate the pace of translation of NCI-supported methods/assays/technologies to the clinic.

Application Deadline: February 28, 2020

https://grants.nih.gov/grants/guide/pa-files/PAR-20-074.html


Agilent Early Career Professor Award

The purpose of the Agilent Early Career Professor Award is to promote and encourage excellent research enabling measurements of importance to Agilent Technologies and the world.

Nomination Deadline: February 28, 2020

Learn more about the Agilent Award>>

 

Arnold and Mabel Beckman Foundation Advanced Light-Sheet Microscopy Program

The Arnold and Mabel Beckman Foundation’s mission is to provide funding for promising technologies, particularly in cutting edge instrumentation and interfaces between disciplines.

Application Deadline: March 6, 2020

Learn more about the Beckman Award>>

 

Neuroendocrine Tumor Research Foundation Grants

We invite innovative and transformative research proposals in NETs to help bring the field closer to more effective therapies. We offer four different neuroendocrine cancer research grants (Accelerator, Investigator, Pilot, and Mentored Awards) with cancer research grants ranging from $100,000 to $1.2 million.

Letters of Intent Deadline: March 9, 2020

Learn more about the NET Grant>>


DoD Breast Cancer Research Program Funding Opportunities FY20

The FY20 Defense Appropriation Act is providing funding to the Department of Defense Breast Cancer Research Program (BCRP) to support innovative, high-impact research with clinical relevance that will accelerate progress to end breast cancer for Service members, Veterans, and the general public.

  • Breakthrough Award Levels 1 and 2 – Letter of Intent Due March 12, 2020
  • Breakthrough Award Level 3 – Preproposal due March 13, 2020
  • Breakthrough Award Level 4 – Preproposal due March 13, 2020
  • Era of Hope Scholar Award – Letter of Intent due March 12, 2020
  • Innovator Award – Preproposal due March 13, 2020
Learn more about the DoD Breast Program Funding>>


Co-infection and Cancer (R21 and R01)

The purpose of this FOA is to enhance mechanistic and epidemiologic investigations addressing the roles of co-infection.

Application Deadline (R21): March 17, 2020

Application Deadline (R01): March 6, 2020

Learn more about co-infection R21 and R01>>

Methods and Measurement in Research with Sexual and Gender Minority (SGM) Populations (R21)

The purpose of this initiative is to support research projects to advance the measurement of constructs relevant to health research with sexual and gender minority (SGM) populations.

Application Deadline: March 13, 2020

Learn more about the SGM R21>>


Samuel Waxman Cancer Research Foundation

The Samuel Waxman Cancer Research Foundation (SWCRF) is pleased to announce two new RFAs. One deals with bladder cancer research and the other RFA is with the Israel Cancer Research Fund (ICRF) and Alan B. Slifka Foundation (ABSF) to form collaborations with Israeli investigators.

Application Deadline: March 15, 2020

Learn more about the Waxman Research Award>>


Sontag Foundation Distinguished Scientist Award

This award provides career and research support to early career scientists who demonstrate outstanding promise for making scientific and medical breakthroughs in the field of brain cancer research.

Application Deadline: March 16, 2020

Learn more about the Sontag Award>>

Damon Runyon-Sohn Pediatric Cancer Fellowship Award

This award provides funding to basic scientists and clinicians who conduct research with the potential to significantly impact the prevention, diagnosis or treatment of one or more pediatric cancers.

Application Deadline: March 16, 2020

Learn more about the Damon Runyon-Sohn Award>>

 

Damon Runyon Cancer Research Foundation Fellowship Award

The Foundation encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention.

Application Deadline: March 16, 2020

Learn more about the Damon Runyon Fellowship Award>>


Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01)

This FOA solicits research projects that seek to model the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in health, illness, recovery, and overall wellbeing.

Application Deadline: March 17, 2020


Radiobiology of High Linear Energy Transfer (High LET) Exposure in Cancer Treatment (R01)

Through this FOA, the NCI invites the submission of meritorious applications, which are expected to be well-balanced in terms of interdisciplinary science that spans approaches in both radiation biology and radiation physics research.

Application Deadline: March 19, 2020

Learn more about the NCI High LET Award>>


Vera and Joseph Dresner Foundation MDS Research Fund: Early Career Awards and Established Investigator

This fund will expand the foundation’s investments in support of cutting-edge MDS research and related programs that will lead to the future standards of care and ultimately cure.

Letters of Intent Due: March 20, 2020

Learn more about the Vera Dresner Foundation Awards>>

 

Prostate Cancer Foundation Young Investigator Awards

The Prostate Cancer Foundation champions investment in human capital to fast-forward solutions for prostate cancer with the ultimate goal of ending death and suffering from metastatic prostate cancer.

Application Deadline: March 23, 2020

Learn more about the prostate foundation award>>


HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3)

The purpose of this FOA is to solicit cooperative agreement applications that propose clinical trials to test the comparative effectiveness of existing therapies for prevention or management of pain while reducing risk of addiction.

Application Deadline: March 24, 2020

Learn more about the HEAL initiative for pain management>>


Department of Defense Lung Cancer Research Program

The FY20 Defense Appropriations Act provides funding to the Department of Defense Lung Cancer Research Program (LCRP) to support innovative, high-impact lung cancer research. Pre-application and application deadlines will be available when the Program Announcements are released.

Learn more about the DoD Lung Award>>

 

Charles H. Hood Foundation Child Health Research Awards Program

The intent of this Awards Program is to support newly independent faculty, provide the opportunity to demonstrate creativity, and assist in the transition to other sources of research funding.

Application Deadline: March 27, 2020

Learn more about the Hood Award>>

 

The Harrington Scholar-Innovator Award

This Award recognizes physician-scientist innovators throughout the US and Canada, whose research has the potential to change standard of care. The Scholar-Innovator Award provides research and drug development support to help bridge the gap between basic discovery and the clinical realm.

Letter of Intent Due: March 27, 2020

Learn more about the Harrington Award>>


Human Frontier Science Program Research Grants (Program Grants & Young Investigators)  

HFSP Research Grants support innovative basic research into fundamental biological problems with emphasis placed on novel and interdisciplinary approaches that involve scientific exchanges across national and disciplinary boundaries

Letters of Intent Due: March 30, 2020

Learn more about the HFSP Grant>>


HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3)

This FOA encourages UG3/UH3 phased cooperative research applications to conduct efficient, large-scale pragmatic or implementation trials to improve pain management and reduce the unnecessary use of opioid medications.

Application Deadline: March 30, 2020

Learn more about HEAL initiative for opiod prescribing>>


Alex’s Lemonade Stand Familial RUNX1 Grant Program

The RUNX1 Research Program is dedicated to advancing areas of research of particular importance to families affected by familial platelet disorders (FPDs) leading to acute myeloid leukemia (AML) due to germline RUNX1 mutations with the ultimate goal of developing effective therapies to prevent the onset of AML.

Application Deadline: April 1, 2020

https://www.alexslemonade.org/campaign/researchers-reviewers/runx1


Prostate Cancer Foundation Awards

The PCF) is pleased to announce a Request for Team Science Applications for PCF Challenge Awards for investigations of metastatic, lethal prostate cancer. These awards will be funded depending on the level of innovation in applications received.

Application Deadline: April 17, 2020

https://res.cloudinary.com/pcf/image/upload/v1579907762/2020_Challenge_Award_RFA_fd6q84.pdf


HIV/AIDS and the Tumor Niche (U54)

The purpose of FOA is to advance our understanding of the role of the tumor niche or microenvironment in the risks, development, progression, and diagnosis of cancer observed in individuals with an underlying HIV infection or AIDS.

Application Deadline: April 15, 2020

Learn more about HIV/AIDS award>>


Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21 and R01)

The purpose of the initiative is to support multidisciplinary exploratory or developmental research to understand the underlying etiologic factors and mechanisms that contribute to population-level disparities in chronic liver diseases and liver cancer in the U.S.

Application Deadlines: April 1, 2020

Learn more about the R21 Liver disease award>>

Learn more about the R01 Liver disease award>>


V Foundation Grants

The V Foundation funds research for many types of cancer. Their Scientific Advisory Committee selects grant recipients through a highly competitive process and invest in promising people and projects.

Application Deadline: April 2, 2020

Learn more about the V Foundation Grants>>

 

Genomic Expert Curation Panels (U24)

The purpose of this FOA is to establish expert panels that will select genes and genomic variants associated with diseases or conditions of high priority to participating NIH Institutes and Centers (ICs) and systematically determine their clinical significance for diagnosis and treatment of these diseases or conditions.

Application Deadline: May 27, 2020

Learn more about genomic panels U24>>


Cancer Research Institute Postdoctoral Fellowship

The CRI Irvington Postdoctoral Fellowship Program supports qualified young scientists at leading universities and research centers around the world who wish to receive training in fundamental immunology or cancer immunology.

Application Deadline: April 1, 2020

Learn more about the CRI fellowship>>

Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 and R21)

The purpose of this FOA is to support research projects designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions Initiative.

Application Deadline: April 30, 2020

Learn more about the NCI R01 Provocative Questions Award>>

Learn more about the NCI R21 Provocative Questions Award>>


The Mark Foundation Emerging Leader Award

This Award provides grant support to early career investigators conducting high-impact, high-risk cancer research. This award is intended to support highly promising projects for which other sources of funding are not readily available or for a separate innovative endeavor that will allow the applicant to pursue a distinct and novel research direction.

Letter of Intenet Due: May 10, 2020

https://themarkfoundation.org/portfolio-overview/2019-emerging-leader-award/


Ovarian Cancer Research Fund Alliance Collaborative Research Development Grant

This Grant provides funds for large ovarian cancer research projects that involve several investigators within one institution or collaborations between groups in multiple institutions.

Letter of Intent Due: May 15, 2020

https://ocrahope.org/research/for-grantees/application-process/


When Everyone Survives Foundation RFP

This RFP is offered by the When Everyone Survives Foundation (WES Leukemia Research Foundation) to solicit innovative research in leukemia.

Application Deadline: June 1, 2020

https://www.wheneveryonesurvives.org/grant_application


Alex's Lemonade Stand Foundation Psychosocial Family Impact Grants

These Grants focus on psychosocial and behavioral health outcomes for children diagnosed with cancer and their families.

Letter of Intent Due: June 15, 2020

https://www.alexslemonade.org/researchers-reviewers/applicants


Alex's Lemonade Stand Foundation Psychosocial Launch Grants

These Grants focus on psychosocial and behavioral health outcomes for children diagnosed with cancer and their families.

Letter of Intent Due: June 15, 2020

https://www.alexslemonade.org/researchers-reviewers/applicants




Surgical Disparities Research (R01)

The purpose of this (FOA) is to support investigative and collaborative research focused on understanding and addressing disparities in surgical care and outcomes, in minority and health disparity populations. 

Application Deadlines: June 5, 2020; June 5, 2021, June 5, 2022. Resubmission/revision applications: July 5, 2020, July 5, 2021, July 5, 2022



Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21)

The purpose of this FOA is to invite exploratory/developmental research grant applications (R21) for the development of innovative methods and algorithms in biomedical computing, informatics, and data science addressing priority needs across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. 

Application Deadline: June 9, 2020



Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01)

The purpose of this FOA is to invite Cooperative Agreement (U01) applications for the development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. 

Application Deadline: June 9, 2020



Advanced Development of Informatics Technologies for Cancer Research and Management (U24) 

The purpose of this FOA is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. 

Application Deadline: June 9, 2020



Sustained Support for Informatics Technologies for Cancer Research and Management (U24) 

The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for the continued development and sustainment of high value informatics research resources to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. 

Application Deadline: June 9, 2020